Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Cash & Short-Term Investments

$50.83M

Quarterly · Period ending: · USD

LCTX logo

LCTX Cash & Short-Term Investments

Latest reported$50.83M
LCTX Quarterly Cash & Short-Term Investments ($5.10M → $50.83M)
High-resolution chart · PNG

LCTX cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
50,829,000
53,381,000
55,781,000
40,486,000
42,288,000
47,905,000
47,805,000
32,711,000
38,496,000
43,621,000
35,492,000
41,332,000
45,925,000
46,814,000
57,875,000
66,355,000
72,030,000
79,944,000
58,358,000
65,104,000
68,746,000
62,364,000
41,562,000
38,046,000
44,623,000
49,759,000
30,716,000
35,684,000
16,687,000
27,096,000
30,741,000
21,439,000
29,155,000
31,379,000
38,175,000
18,173,000
15,770,000
24,731,000
22,715,000
31,354,000
28,321,000
27,961,000
42,982,000
29,378,000
31,465,000
25,829,533
29,486,909
7,416,235
15,721,508
6,637,834
5,495,478
6,717,343
14,306,296
9,896,335
4,349,967
7,830,347
12,659,843
16,487,906
22,211,897
26,230,298
27,381,941
30,136,979
33,324,924
25,421,594
18,056,089
11,173,062
12,189,081
7,942,577
4,692,726
541,106
12,279
52,082
172,461
307,471
9,501
13,760
127,242
277,280
561,017
755,553
999,436
1,089,146
1,833,774
175,564
588,540
711,766
1,370,762
1,568,845
1,751,128
2,119,803
717,184
1,181,535
650,395
723,519
1,284,432
1,829,139
501,291
987,470
1,652,748
1,937,086
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.